Development of a human intestinal microphysiological system for the study of immune responses to protozoan parasites
Development of a human intestinal microphysiological system for the study of immune responses to protozoan parasites
批准号:
10733303
负责人:
David J Beebe
金额:
$76.91万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-05 至 2028-06-30
关键词:
3-DimensionalAddressApicalArchitectureBindingBiological ModelsBiomimeticsBloodBlood VesselsCell CommunicationCell Culture TechniquesCellsCessation of lifeClostridium difficileCoculture TechniquesCongenital AbnormalityCystDataDevelopmentDevicesDiseaseDisease ProgressionEndotheliumEntamoeba histolyticaEnteralEnvironmentEpithelial CellsEpitheliumFoodFood ContaminationGene ExpressionGoalsGrowthHelper-Inducer T-LymphocyteHumanHypoxiaImmuneImmune responseImmunityImmunocompromised HostImmunologic MonitoringImmunologyIndividualInfantInfectionInfection ControlInflammationInnate Immune ResponseIntestinal parasiteIntestinesInvestigationKnowledgeLymphaticLymphatic Endothelial CellsMalignant NeoplasmsMeasuresMediatingMicrobiologyMicrofluidic MicrochipsMicrofluidicsModelingMonitorMorbidity - disease rateMucous body substanceMusNutrientOocystsOralOrganoidsParasite ControlParasitesParasitic DiseasesParasitic infectionPathway interactionsPersonsPhagocytosisPhysiologicalPopulationPregnant WomenProductionResearchRoleRouteS100 ProteinsS100A11 geneSideSmall IntestinesSystemTissuesToll-like receptor 11Toxoplasma gondiiToxoplasmosisTreesVaccinesVascular Endothelial CellWaterWorkcytokineenteric infectionexperimental studyhuman diseasehuman migrationhuman modelhuman pathogenimprovedin vitro Modelintestinal epitheliumlymphatic vasculaturemembermicrophysiology systemmigrationmodel developmentmonocytemortalitymouse modelneutrophiloral infectionpathogenpathogenic bacteriarecruitresponsetransmission processvaccine accessvaccine developmentwaterborne
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Microphysiological systems have great potential for modeling human disease but advanced in vitro models of
parasitic infection and immunity are severely underrepresented. Parasites are major causes of morbidity and
mortality globally, infecting millions of people every year, yet, there are no effective vaccines available for any
enteric parasitic infection. Oral transmission via contaminated food or water is the most common route of
parasitic infection for humans, but our knowledge of parasite/host interactions, including how parasites interact
with immune cells to either cause disease or elicit a protective immune response, within the intestinal tract is
very limited. There is a critical need to create improved in vitro models of human immune-parasite interactions
to capture key features present during parasitic infection establishment and disease progression. To address
this need we will develop a microphysiological gut vasculature lumen system based on the LumeNEXT
microfluidic device system. This 3-dimensional cell culture device recapitulates the gut architecture and
includes a human intestinal epithelial lumen flanked by blood and lymphatic vasculature. With these advanced
in vitro models, we will introduce parasites into the intestinal epithelium and human immune cells into the
vasculature to monitor parasitic disease and immune response. Our goal is to create a microphysiological
system that can be used for the study of any protozoan parasite. For this proposal, we will use the protozoan
parasites Toxoplasma gondii (T. gondii) and Entamoeba histolytica (E. histolytica) because 1) they are human
pathogens of global importance, 2) they are on distinct branches of the protist evolutionarily tree, 3) they have
defined lab growth conditions and genetically tagged marker strains, 4) our lab has recently developed the
unique ability to produce large numbers of the highly infectious oocysts and cysts forms of both T. gondii. Our
data shows that T. gondii infection of the intestinal epithelial lumen in our in vitro model system elicits an active
immune response and migration of human immune cells from the vasculature. In this project, we will use these
3D biomimetic gut-vasculature lumen models to address critical knowledge gaps of the human immune
responses to T. gondii and E. histolytica. We will incorporate an anaerobic environment so that the immune
responses can be defined under hypoxic conditions. These experiments will provide the foundational
understanding of the human innate immune responses to intestinal T. gondii infection that are essential for
vaccine development. We will also model E. histolytica invasive disease using nutrient limitation and co-culture
with Clostridiodes difficile. The advances we will achieve in this proposal will allow the microbiology and
immunology fields to determine the immune responses to the biologically relevant stages of intestinal parasites
in human models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
-
批准号:10333399
-
项目类别:
-
资助金额:$76.42万
-
财政年份:2021
-
负责人:David J Beebe
-
依托单位:
Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
-
批准号:10552700
-
项目类别:
-
资助金额:$77.08万
-
财政年份:2021
-
负责人:David J Beebe
-
依托单位:
Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
-
批准号:10209529
-
项目类别:
-
资助金额:$72.84万
-
财政年份:2021
-
负责人:David J Beebe
-
依托单位:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
-
批准号:9916997
-
项目类别:
-
资助金额:$61.09万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
-
批准号:10331769
-
项目类别:
-
资助金额:$62.0万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
-
批准号:10686449
-
项目类别:
-
资助金额:$77.75万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
-
批准号:10263962
-
项目类别:
-
资助金额:$85.43万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
-
批准号:10094211
-
项目类别:
-
资助金额:$63.43万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
A multiplexed micro scale assay for real time analysis of pediatric immune cell function
-
批准号:10380807
-
项目类别:
-
资助金额:$36.04万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
A multiplexed micro scale assay for real time analysis of pediatric immune cell function
-
批准号:10132990
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
-
批准号:10552039
-
项目类别:
-
资助金额:$62.16万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
-
批准号:10707411
-
项目类别:
-
资助金额:$77.75万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
-
批准号:10038030
-
项目类别:
-
资助金额:$77.54万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
A multiplexed micro scale assay for real time analysis of pediatric immune cell function
-
批准号:10599320
-
项目类别:
-
资助金额:$35.74万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Microscale models of inflammation and its resolution
-
批准号:10372948
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2018
-
负责人:David J Beebe
-
依托单位:
Microscale models of inflammation and its resolution
-
批准号:9904469
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2018
-
负责人:David J Beebe
-
依托单位:
Project 2: Predicting Treatment Responses Using Single Cell RNA Sequencing and Bioengineered Patient-derived Organotypic Models of HNC
-
批准号:10495294
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2016
-
负责人:David J Beebe
-
依托单位:
Project 2: Predicting Treatment Responses Using Single Cell RNA Sequencing and Bioengineered Patient-derived Organotypic Models of HNC
-
批准号:10673977
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2016
-
负责人:David J Beebe
-
依托单位:
An automated high-throughput tissue model for screening metastatic effectors
-
批准号:8817450
-
项目类别:
-
资助金额:$61.05万
-
财政年份:2015
-
负责人:David J Beebe
-
依托单位:
An automated high-throughput tissue model for screening metastatic effectors
-
批准号:8994280
-
项目类别:
-
资助金额:$62.56万
-
财政年份:2015
-
负责人:David J Beebe
-
依托单位:
海外基金